Mosaiques Diagnostic GmbH
The mosaiques diagnostics GmbH, based in Hannover, is a world-leading company in the field of clinical proteomics and diagnostics. Since its founding in 2002, the company has specialized in the early and reliable detection of diseases, enabling personalized medicine during therapy and drug development[1][2].
Core Competencies and Technologies
The mosaiques diagnostics GmbH uses a unique, proprietary technology based on the analysis of multidimensional diagnostic polypeptide biomarker patterns (DiaPat). These patterns are obtained from the rapid and high-precision analysis of up to 6,000 polypeptide fragments, which are predominantly found in urine, but also in other bodily fluids such as bile and cerebrospinal fluid[1]. The basis is the innovative CE-MS technology (capillary electrophoresis coupled with mass spectrometry), which enables the separation of body fluids in less than an hour. The company's own software evaluates extensive amounts of data within minutes[1][2].
Products and Services
The company offers highly specialized diagnostic tests that can detect diseases such as cardiovascular diseases, kidney diseases, biliary tract diseases and urogenital diseases at an early stage. In addition, tests for further indications such as pancreatic cancer and nephrotoxic effects of drugs are under development[1][4]. The diagnosis is painless and low-risk based on specific patterns of several simultaneously detected biomarkers, which allows a differentiated disease classification and thus makes a decisive contribution to early detection[1].
Mission and Values
Mosaiques is committed to improving patient care through precise, individual diagnoses and personalized therapy approaches. The company brings together clinical proteome analyses with the highest data quality to provide reliable biomarkers at the molecular level. The goal is to avoid serious organ damage and to enable therapy-optimized decisions at an early stage[1][2].
Sustainability and Social Responsibility
The development of low-risk diagnostic procedures that increase patient comfort and reduce invasive methods underscores mosaiques' commitment to sustainable health solutions. Through precise early detection, the company also contributes to the more efficient use of medical resources and to improving the quality of life of patients[1][2].
In summary, the mosaiques diagnostics GmbH is an innovative pioneer in the field of clinical proteomics, which, with its proprietary CE-MS technology and an extensive biomarker database, is significantly shaping the medicine of tomorrow - towards precise, personalized and sustainable diagnostics.
